Home
About
Overview
Sharing Data
ORCID
Help
History (182)
Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase III study: the role of process control.
Parainfluenza Virus 3, Human
Signaling mechanisms that regulate glucose transport.
Nitric oxide-mediated inhibition of Hdm2-p53 binding.
Clinical symptoms and risk factors in cerebral microangiopathy patients.
See All 182 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical symptoms and risk factors in cerebral microangiopathy patients.
Okroglic S, Widmann CN, Urbach H, Scheltens P, Heneka MT. Clinical symptoms and risk factors in cerebral microangiopathy patients. PLoS One. 2013; 8(2):e53455.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Aging
Cerebral Small Vessel Diseases
Female
Humans
Hypertension
Male
Obesity
Retrospective Studies
Risk Factors
authors with profiles
Michael Thomas Heneka MD